Does switching to fingolimod from natalizumab result in short-term relapse exacerbation?

V. G. Jokubaitis; V. Li; T. Kalincik; G. Izquierdo; S. Hodgkinson; R. Alroughani; J. Lechner-Scott; A. Lugaresi; P. Duquette; M. Girard; M. Barnett; F. Grand'Maison; M. Trojano; M. Slee; G. Giuliani; C. Shaw; C. Boz; J. Haartsen; D.  Liew; H. Butzkueven; MSBase Study Group

doi:10.1177/1352458513502433

Does switching to fingolimod from natalizumab result in short-term relapse exacerbation?

V. G. Jokubaitis
, V. Li
, T. Kalincik
, G. Izquierdo
, S. Hodgkinson
, R. Alroughani
, J. Lechner-Scott
, A. Lugaresi
, P. Duquette
, M. Girard
, M. Barnett
, F. Grand'Maison
, M. Trojano
, M. Slee
, G. Giuliani
, C. Shaw
, C. Boz
, J. Haartsen
, D. Liew
, H. Butzkueven

MSBase Study Group

College of Medicine and Public Health

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	55-56
Number of pages	2
Journal	Multiple Sclerosis
Volume	19
Issue number	Suppl. 11
DOIs	https://doi.org/10.1177/1352458513502433
Publication status	Published - Oct 2013

Keywords

fingolimod
natalizumab
exacerbation

Access to Document

10.1177/1352458513502433Licence: In Copyright

Cite this

Jokubaitis, V. G., Li, V., Kalincik, T., Izquierdo, G., Hodgkinson, S., Alroughani, R., Lechner-Scott, J., Lugaresi, A., Duquette, P., Girard, M., Barnett, M., Grand'Maison, F., Trojano, M., Slee, M., Giuliani, G., Shaw, C., Boz, C., Haartsen, J., Liew, D., ... MSBase Study Group (2013). Does switching to fingolimod from natalizumab result in short-term relapse exacerbation? Multiple Sclerosis, 19(Suppl. 11), 55-56. https://doi.org/10.1177/1352458513502433

@article{c8b3d54f0a56441a88f8524289cb8fdc,

title = "Does switching to fingolimod from natalizumab result in short-term relapse exacerbation?",

keywords = "fingolimod, natalizumab, exacerbation",

author = "Jokubaitis, \{V. G.\} and V. Li and T. Kalincik and G. Izquierdo and S. Hodgkinson and R. Alroughani and J. Lechner-Scott and A. Lugaresi and P. Duquette and M. Girard and M. Barnett and F. Grand'Maison and M. Trojano and M. Slee and G. Giuliani and C. Shaw and C. Boz and J. Haartsen and D. Liew and H. Butzkueven and \{MSBase Study Group\}",

year = "2013",

month = oct,

doi = "10.1177/1352458513502433",

language = "English",

volume = "19",

pages = "55--56",

journal = "Multiple Sclerosis",

issn = "1352-4585",

publisher = "SAGE Publications Ltd",

number = "Suppl. 11",

}

Jokubaitis, VG, Li, V, Kalincik, T, Izquierdo, G, Hodgkinson, S, Alroughani, R, Lechner-Scott, J, Lugaresi, A, Duquette, P, Girard, M, Barnett, M, Grand'Maison, F, Trojano, M, Slee, M, Giuliani, G, Shaw, C, Boz, C, Haartsen, J, Liew, D, Butzkueven, H & MSBase Study Group 2013, 'Does switching to fingolimod from natalizumab result in short-term relapse exacerbation?', Multiple Sclerosis, vol. 19, no. Suppl. 11, pp. 55-56. https://doi.org/10.1177/1352458513502433